FTH · Faeth Therapeutics, Inc.
$32.34
+3.79 (+13.27%)
At close · Aug 14
Going-concern doubt
— cleared Aug 4, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 4, 2026Market Cap
$835.68M
Shares
25.84M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding FTH
9 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund | — | 48,771 | $1,298,284 | 0.13% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 7,750 | $244,280 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 4,576 | $96,737 | 0.00% | Long | 2026-05-31 | |
| Dimensional U.S. Small Cap ETF | — | 1,360 | $36,203 | 0.00% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 1,416 | $29,934 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 1,253 | $26,488 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 578 | $12,219 | 0.00% | Long | 2026-05-31 | |
| U.S. MICRO CAP PORTFOLIO | — | 369 | $9,823 | 0.00% | Long | 2026-04-30 | |
| Guggenheim Active Allocation Fund | GUG | 6 | $127 | 0.00% | Long | 2026-05-29 |
Showing 1–9 of 9 positions
Key facts
CIK
1829802
CUSIP
81728A207
13F (30d)
49 filings
47 filers
Visit website
Investor relations